As is well known for other tumor markers such as CA 19-9, one can also detect elevated levels in benign diseases of the pancreas. In conclusion, pancreatic cancer Tumor M2-PK and CA 19-9 cannot be ...

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

There is no one test, either blood test or x-ray, that can be ordered to see if pancreatic cancer is present. A series of tests are done, and they may include: a complete metabolic panel, liver panel, ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and deadly forms of cancer. This means it grows and ...

Unfortunately, many solid tumors metastasize to other organs, which limits treatment efficacy. One specific cancer type that is extremely aggressive and often metastasizes includes pancreatic cancer.

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

TLSs serve as the immune system’s on-site responders, forming in chronically inflamed tissues, including tumors, to bolster ...

The latest grant is intended to support the company’s Phase 1 PANACEA study evaluating the safety and tolerability of MT-601 in patients with metastatic pancreatic cancer. Marker Therapeutics ...

A revolutionary blood test, TriOx, developed by researchers at the University of Oxford, is demonstrating significant ...